Last 12 months
Inside the activity.
0 purchase rows · 29 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 5 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 9 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 16, 2017 Filed May 18, 2017 20:41 UTC |
BRITELL JENNE KDirector
|
GrantCommon Stock | 1,573 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-17-000133 · wf-form4_149514006603711.xml · nonDerivative · entry 1 BRITELL JENNE K · CIK 0001142318 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 21,476 F1 · security: Represents an award of restricted stock units granted on May 16, 2017. Read SEC document |
| April 24, 2017 Filed Apr 26, 2017 20:34 UTC |
BRITELL JENNE KDirector
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 6,111 | $57.67 Strike: $57.67 | $352,421.37 |
DisclosureSEC source: 0001022079-17-000122 · wf-form4_149323886844998.xml · derivative · entry 3 BRITELL JENNE K · CIK 0001142318 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 0 Underlying: Common Stock · 6,111 shares Expires 2021-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options vested in three equal annual installments beginning with the first on May 17, 2012, the second on May 17, 2013 and the final on May 17, 2014. Read SEC document |
| April 24, 2017 Filed Apr 26, 2017 20:34 UTC |
BRITELL JENNE KDirector
|
SaleCommon Stock | 6,111 | $104.03 | $635,727.33 |
DisclosureSEC source: 0001022079-17-000122 · wf-form4_149323886844998.xml · nonDerivative · entry 2 BRITELL JENNE K · CIK 0001142318 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 19,903 F1 · price: This transaction was executed in multiple trades at prices ranging from $104.008 to $104.060. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors. Read SEC document |
| April 24, 2017 Filed Apr 26, 2017 20:34 UTC |
BRITELL JENNE KDirector
|
Exercise / conversionCommon Stock | 6,111 | $57.67 | $352,421.37 |
DisclosureSEC source: 0001022079-17-000122 · wf-form4_149323886844998.xml · nonDerivative · entry 1 BRITELL JENNE K · CIK 0001142318 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 25,996 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 20, 2017 Filed Apr 24, 2017 20:18 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 28,500 | $56.82 Strike: $56.82 | $1,619,370.00 |
DisclosureSEC source: 0001022079-17-000120 · wf-form4_149306509747504.xml · derivative · entry 7 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 28,500 shares Expires 2021-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on February 10, 2017. F5 · derivative.exercise_date: The options vested in three equal annual installments beginning with the first on February 15, 2012, the second on February 15, 2013 and the final on February 15, 2014. Read SEC document |
| April 20, 2017 Filed Apr 24, 2017 20:18 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 1,013 | $55.65 Strike: $55.65 | $56,373.45 |
DisclosureSEC source: 0001022079-17-000120 · wf-form4_149306509747504.xml · derivative · entry 6 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,013 shares Expires 2020-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on February 10, 2017. F4 · derivative.exercise_date: The options vested in three equal annual installments beginning with the first on February 10, 2011, the second on February 10, 2012 and the final on February 10, 2013. Read SEC document |
| April 20, 2017 Filed Apr 24, 2017 20:18 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
SaleCommon Stock | 28,500 | $100.00 | $2,850,000.00 |
DisclosureSEC source: 0001022079-17-000120 · wf-form4_149306509747504.xml · nonDerivative · entry 4 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,327 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on February 10, 2017. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| April 20, 2017 Filed Apr 24, 2017 20:18 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
Exercise / conversionCommon Stock | 28,500 | $56.82 | $1,619,370.00 |
DisclosureSEC source: 0001022079-17-000120 · wf-form4_149306509747504.xml · nonDerivative · entry 3 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,822 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on February 10, 2017. Read SEC document |
| April 20, 2017 Filed Apr 24, 2017 20:18 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
SaleCommon Stock | 1,013 | $100.00 | $101,300.00 |
DisclosureSEC source: 0001022079-17-000120 · wf-form4_149306509747504.xml · nonDerivative · entry 2 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,322 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on February 10, 2017. Read SEC document |
| April 20, 2017 Filed Apr 24, 2017 20:18 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
Exercise / conversionCommon Stock | 1,013 | $55.65 | $56,373.45 |
DisclosureSEC source: 0001022079-17-000120 · wf-form4_149306509747504.xml · nonDerivative · entry 1 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,335 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on February 10, 2017. Read SEC document |
| April 03, 2017 Filed Apr 5, 2017 20:53 UTC |
RING TIMOTHY MDirector
|
GrantPhantom Stock Units · Derivative | 315 | $97.62 Strike: $0.00 | $30,750.30 |
DisclosureSEC source: 0001022079-17-000109 · wf-form4_149142562493628.xml · derivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,216.271 Underlying: Common Stock · 315 shares Expires not disclosed F1 · derivative.exercise_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F1 · derivative.expiration_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F2 · balance_after: Total number of phantom stock units accrued as of the transaction date in the reporting person's deferred compensation account includes phantom stock units credited as a result of dividend reinvestment transactions exempt from reporting pursuant to Rule 16a-11. Read SEC document |
| March 16, 2017 Filed Mar 20, 2017 20:37 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 13,987 | $55.65 Strike: $55.65 | $778,376.55 |
DisclosureSEC source: 0001022079-17-000107 · wf-form4_149004220633264.xml · derivative · entry 4 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,013 Underlying: Common Stock · 13,987 shares Expires 2020-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on February 10, 2017. F3 · derivative.exercise_date: The options vested in three equal annual installments beginning with the first on February 10, 2011, the second on February 10, 2012 and the final on February 10, 2013. Read SEC document |
| March 16, 2017 Filed Mar 20, 2017 20:37 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
SaleCommon Stock | 13,987 | $100.00 | $1,398,700.00 |
DisclosureSEC source: 0001022079-17-000107 · wf-form4_149004220633264.xml · nonDerivative · entry 2 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,322 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on February 10, 2017. Read SEC document |
| March 16, 2017 Filed Mar 20, 2017 20:37 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
Exercise / conversionCommon Stock | 13,987 | $55.65 | $778,376.55 |
DisclosureSEC source: 0001022079-17-000107 · wf-form4_149004220633264.xml · nonDerivative · entry 1 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,309 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on February 10, 2017. Read SEC document |
| March 03, 2017 Filed Mar 6, 2017 21:40 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
SaleCommon Stock | 4,478 | $98.29 | $440,142.62 |
DisclosureSEC source: 0001022079-17-000105 · wf-form4_148883643050293.xml · nonDerivative · entry 1 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,322 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 22, 2016. Read SEC document |
| March 03, 2017 Filed Mar 6, 2017 21:39 UTC |
Doherty Catherine T.SVP, Group Exec. Clin. Fran.
|
SaleCommon Stock | 6,028 | $98.29 | $592,492.12 |
DisclosureSEC source: 0001022079-17-000104 · wf-form4_148883634583941.xml · nonDerivative · entry 4 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,155 F3 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on January 30, 2017. Read SEC document |
| March 02, 2017 Filed Mar 3, 2017 22:15 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
Tax withholdingCommon Stock | 4,824 | $98.12 | $473,330.88 |
DisclosureSEC source: 0001022079-17-000101 · wf-form4_148857932530003.xml · nonDerivative · entry 3 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,800 F3 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. F4 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| March 02, 2017 Filed Mar 3, 2017 22:15 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
GrantCommon Stock | 9,302 | $98.12 | $912,712.24 |
DisclosureSEC source: 0001022079-17-000101 · wf-form4_148857932530003.xml · nonDerivative · entry 2 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,619 F2 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 13, 2014, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| March 02, 2017 Filed Mar 3, 2017 22:13 UTC |
Klug Robert AVP, Corporate Controller
|
Tax withholdingCommon Stock | 419 | $98.12 | $41,112.28 |
DisclosureSEC source: 0001022079-17-000099 · wf-form4_148857921991828.xml · nonDerivative · entry 2 Klug Robert A · CIK 0001347843 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,330 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. F3 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| March 02, 2017 Filed Mar 3, 2017 22:13 UTC |
Klug Robert AVP, Corporate Controller
|
GrantCommon Stock | 1,217 | $98.12 | $119,412.04 |
DisclosureSEC source: 0001022079-17-000099 · wf-form4_148857921991828.xml · nonDerivative · entry 1 Klug Robert A · CIK 0001347843 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,722 F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 13, 2014, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| March 02, 2017 Filed Mar 3, 2017 22:08 UTC |
Davis J. E.EVP, General Diagnostics
|
Tax withholdingCommon Stock | 7,421 | $98.12 | $728,148.52 |
DisclosureSEC source: 0001022079-17-000095 · wf-form4_148857891153241.xml · nonDerivative · entry 2 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,543 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. F3 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| March 02, 2017 Filed Mar 3, 2017 22:08 UTC |
Davis J. E.EVP, General Diagnostics
|
GrantCommon Stock | 12,520 | $98.12 | $1,228,462.40 |
DisclosureSEC source: 0001022079-17-000095 · wf-form4_148857891153241.xml · nonDerivative · entry 1 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,918 F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 13, 2014, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| March 02, 2017 Filed Mar 3, 2017 22:10 UTC |
GUINAN MARKExecutive Vice President & CFO
|
Tax withholdingCommon Stock | 7,420 | $98.12 | $728,050.40 |
DisclosureSEC source: 0001022079-17-000097 · wf-form4_148857902274030.xml · nonDerivative · entry 2 GUINAN MARK · CIK 0001505998 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,917 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. Read SEC document |
| March 02, 2017 Filed Mar 3, 2017 22:10 UTC |
GUINAN MARKExecutive Vice President & CFO
|
GrantCommon Stock | 14,309 | $98.12 | $1,403,999.08 |
DisclosureSEC source: 0001022079-17-000097 · wf-form4_148857902274030.xml · nonDerivative · entry 1 GUINAN MARK · CIK 0001505998 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,337 F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 13, 2014, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| March 02, 2017 Filed Mar 3, 2017 22:07 UTC |
Cunningham EverettSVP, Commercial
|
Tax withholdingCommon Stock | 6,492 | $98.12 | $636,995.04 |
DisclosureSEC source: 0001022079-17-000093 · wf-form4_148857880856322.xml · nonDerivative · entry 2 Cunningham Everett · CIK 0001564777 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,052 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. F3 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| March 02, 2017 Filed Mar 3, 2017 22:07 UTC |
Cunningham EverettSVP, Commercial
|
GrantCommon Stock | 12,520 | $98.12 | $1,228,462.40 |
DisclosureSEC source: 0001022079-17-000093 · wf-form4_148857880856322.xml · nonDerivative · entry 1 Cunningham Everett · CIK 0001564777 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,498 F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 13, 2014, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| March 02, 2017 Filed Mar 3, 2017 22:01 UTC |
Cohen Jon RSVP & Group Exec. Diag. Sol.
|
Tax withholdingCommon Stock | 6,402 | $98.12 | $628,164.24 |
DisclosureSEC source: 0001022079-17-000091 · wf-form4_148857849342881.xml · nonDerivative · entry 2 Cohen Jon R · CIK 0001477972 · SVP & Group Exec. Diag. Sol. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,183 F2 · acquired: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. Read SEC document |
| March 02, 2017 Filed Mar 3, 2017 22:01 UTC |
Cohen Jon RSVP & Group Exec. Diag. Sol.
|
GrantCommon Stock | 12,520 | $98.12 | $1,228,462.40 |
DisclosureSEC source: 0001022079-17-000091 · wf-form4_148857849342881.xml · nonDerivative · entry 1 Cohen Jon R · CIK 0001477972 · SVP & Group Exec. Diag. Sol. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,585 F1 · acquired: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 13, 2014, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| March 02, 2017 Filed Mar 3, 2017 22:00 UTC |
RUSCKOWSKI STEPHEN HDirector · Chairman, President and CEO
|
Tax withholdingCommon Stock | 26,891 | $98.12 | $2,638,544.92 |
DisclosureSEC source: 0001022079-17-000090 · wf-form4_148857838844457.xml · nonDerivative · entry 2 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,888 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. F3 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| March 02, 2017 Filed Mar 3, 2017 22:00 UTC |
RUSCKOWSKI STEPHEN HDirector · Chairman, President and CEO
|
GrantCommon Stock | 47,934 | $98.12 | $4,703,284.08 |
DisclosureSEC source: 0001022079-17-000090 · wf-form4_148857838844457.xml · nonDerivative · entry 1 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,682 F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 13, 2014, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| March 02, 2017 Filed Mar 6, 2017 21:39 UTC |
Doherty Catherine T.SVP, Group Exec. Clin. Fran.
|
SaleCommon Stock | 1,134 | $98.25 | $111,415.50 |
DisclosureSEC source: 0001022079-17-000104 · wf-form4_148883634583941.xml · nonDerivative · entry 3 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,183 F3 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on January 30, 2017. Read SEC document |
| March 02, 2017 Filed Mar 6, 2017 21:39 UTC |
Doherty Catherine T.SVP, Group Exec. Clin. Fran.
|
Tax withholdingCommon Stock | 6,492 | $98.12 | $636,995.04 |
DisclosureSEC source: 0001022079-17-000104 · wf-form4_148883634583941.xml · nonDerivative · entry 2 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,317 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. Read SEC document |
| March 02, 2017 Filed Mar 6, 2017 21:39 UTC |
Doherty Catherine T.SVP, Group Exec. Clin. Fran.
|
GrantCommon Stock | 12,520 | $98.12 | $1,228,462.40 |
DisclosureSEC source: 0001022079-17-000104 · wf-form4_148883634583941.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,809 F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 13, 2014, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 22:15 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
SaleCommon Stock | 470 | $97.77 | $45,951.90 |
DisclosureSEC source: 0001022079-17-000101 · wf-form4_148857932530003.xml · nonDerivative · entry 1 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,317 F1 · shares: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 22, 2016. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 21:50 UTC |
Klug Robert AVP, Corporate Controller
|
Tax withholdingCommon Stock | 69 | $96.42 | $6,652.98 |
DisclosureSEC source: 0001022079-17-000087 · wf-form4_148849143187597.xml · nonDerivative · entry 1 Klug Robert A · CIK 0001347843 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,505 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 21:49 UTC |
Doherty Catherine T.SVP, Group Exec. Clin. Fran.
|
Tax withholdingCommon Stock | 585 | $96.42 | $56,405.70 |
DisclosureSEC source: 0001022079-17-000086 · wf-form4_148849135447499.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,289 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 21:47 UTC |
RUSCKOWSKI STEPHEN HDirector · Chairman, President and CEO
|
Tax withholdingCommon Stock | 3,163 | $96.42 | $304,976.46 |
DisclosureSEC source: 0001022079-17-000085 · wf-form4_148849125315160.xml · nonDerivative · entry 1 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,748 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted share units. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 21:47 UTC |
GUINAN MARKExecutive Vice President & CFO
|
Tax withholdingCommon Stock | 625 | $96.42 | $60,262.50 |
DisclosureSEC source: 0001022079-17-000084 · wf-form4_148849120636793.xml · nonDerivative · entry 1 GUINAN MARK · CIK 0001505998 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,028 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 21:46 UTC |
Cunningham EverettSVP, Commercial
|
Tax withholdingCommon Stock | 585 | $96.42 | $56,405.70 |
DisclosureSEC source: 0001022079-17-000083 · wf-form4_148849115841920.xml · nonDerivative · entry 1 Cunningham Everett · CIK 0001564777 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,978 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 21:43 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
Tax withholdingCommon Stock | 507 | $96.42 | $48,884.94 |
DisclosureSEC source: 0001022079-17-000082 · wf-form4_148849100899652.xml · nonDerivative · entry 1 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,787 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted share units. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 21:42 UTC |
Davis J. E.EVP, General Diagnostics
|
Tax withholdingCommon Stock | 675 | $96.42 | $65,083.50 |
DisclosureSEC source: 0001022079-17-000081 · wf-form4_148849095617330.xml · nonDerivative · entry 1 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,398 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 21:41 UTC |
Cohen Jon RSVP & Group Exec. Diag. Sol.
|
Tax withholdingCommon Stock | 420 | $96.42 | $40,496.40 |
DisclosureSEC source: 0001022079-17-000080 · wf-form4_148849085305492.xml · nonDerivative · entry 1 Cohen Jon R · CIK 0001477972 · SVP & Group Exec. Diag. Sol. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,065 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 27, 2017 Filed Feb 28, 2017 21:49 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
SaleCommon Stock | 440 | $97.39 | $42,851.60 |
DisclosureSEC source: 0001022079-17-000070 · wf-form4_148831856624853.xml · nonDerivative · entry 3 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,294 F3 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 22, 2016. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 21:48 UTC |
Davis J. E.EVP, General Diagnostics
|
Tax withholdingCommon Stock | 600 | $95.68 | $57,408.00 |
DisclosureSEC source: 0001022079-17-000069 · wf-form4_148831851208576.xml · nonDerivative · entry 1 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,073 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 21:50 UTC |
RUSCKOWSKI STEPHEN HDirector · Chairman, President and CEO
|
Tax withholdingCommon Stock | 2,759 | $95.68 | $263,981.12 |
DisclosureSEC source: 0001022079-17-000071 · wf-form4_148831860472579.xml · nonDerivative · entry 1 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,911 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 21:49 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
Tax withholdingCommon Stock | 474 | $95.68 | $45,352.32 |
DisclosureSEC source: 0001022079-17-000070 · wf-form4_148831856624853.xml · nonDerivative · entry 1 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,734 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 21:47 UTC |
Klug Robert AVP, Corporate Controller
|
Tax withholdingCommon Stock | 43 | $95.68 | $4,114.24 |
DisclosureSEC source: 0001022079-17-000068 · wf-form4_148831846122972.xml · nonDerivative · entry 1 Klug Robert A · CIK 0001347843 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,574 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 21:45 UTC |
GUINAN MARKExecutive Vice President & CFO
|
Tax withholdingCommon Stock | 585 | $95.68 | $55,972.80 |
DisclosureSEC source: 0001022079-17-000067 · wf-form4_148831831097670.xml · nonDerivative · entry 1 GUINAN MARK · CIK 0001505998 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,653 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 21:44 UTC |
Doherty Catherine T.SVP, Group Exec. Clin. Fran.
|
Tax withholdingCommon Stock | 638 | $95.68 | $61,043.84 |
DisclosureSEC source: 0001022079-17-000066 · wf-form4_148831826525945.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,874 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 21:42 UTC |
Cunningham EverettSVP, Commercial
|
Tax withholdingCommon Stock | 638 | $95.68 | $61,043.84 |
DisclosureSEC source: 0001022079-17-000065 · wf-form4_148831815219006.xml · nonDerivative · entry 1 Cunningham Everett · CIK 0001564777 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,563 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted share units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.